Stay updated on Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The clinical trial record is available, with details on the study’s treatments, eligibility criteria, outcomes, locations, and completed status.
    Difference
    50%
    Check dated 2026-11-07T16:22:35.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-10-31T16:26:55.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A site-wide banner announces that NIH agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T20:09:40.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The revision label in the footer changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T20:16:41.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T20:30:02.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page instead of the study content. This indicates the page is blocked to access, with the standard header and footer visible.
    Difference
    0.5%
    Check dated 2026-09-26T20:15:58.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial page.